Form 4 for SURG SurgePays, Inc.
Accepted 2024-05-03 00:00:00 ET · period of report 2024-05-01 · accession 0001493152-24-017721 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-03 | 2024-05-01 | SURG | Evers Anthony George | CFO | A - Grant | $0.00 | +66.7K | 77.3K | +625% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Restricted Shares (Common Stock) | 2024-05-01 | A | A | 66,667 | $0.00 | 77,339 | D | — | — | (F1) Represents a restricted stock award granted to the Reporting Person pursuant to the Issuer's 2022 Omnibus Securities and Incentive Plan. The award will vest as to 66,667 RSAs on July 1, 2024, 66,667 RSAs on August 1, 2024, 66,667 RSAs on September 1, 2024, 66,667 RSAs on October 1, 2024, 66,666 RSAs on November 1, 2024, 66,666 RSAs on December 1, 2024, and 200,000 RSAs on December 31, 2025, in each case, subject to Executive's continued employment with the Company through the applicable vesting date. (F2) In connection with the vesting schedule above, the vesting due July 1, 2024, is within sixty days of today's date and is thereby considered to be beneficially owned. (F3) Includes 7,271 shares of Common Stock (held in Mr. Evers' IRA) and options that are currently exercisable. |